Literature DB >> 19328213

Methamphetamine toxicity and messengers of death.

Irina N Krasnova1, Jean Lud Cadet.   

Abstract

Methamphetamine (METH) is an illicit psychostimulant that is widely abused in the world. Several lines of evidence suggest that chronic METH abuse leads to neurodegenerative changes in the human brain. These include damage to dopamine and serotonin axons, loss of gray matter accompanied by hypertrophy of the white matter and microgliosis in different brain areas. In the present review, we summarize data on the animal models of METH neurotoxicity which include degeneration of monoaminergic terminals and neuronal apoptosis. In addition, we discuss molecular and cellular bases of METH-induced neuropathologies. The accumulated evidence indicates that multiple events, including oxidative stress, excitotoxicity, hyperthermia, neuroinflammatory responses, mitochondrial dysfunction, and endoplasmic reticulum stress converge to mediate METH-induced terminal degeneration and neuronal apoptosis. When taken together, these findings suggest that pharmacological strategies geared towards the prevention and treatment of the deleterious effects of this drug will need to attack the various pathways that form the substrates of METH toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19328213      PMCID: PMC2731235          DOI: 10.1016/j.brainresrev.2009.03.002

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  348 in total

1.  Methamphetamine-related stroke: four cases.

Authors:  J A Perez; E L Arsura; S Strategos
Journal:  J Emerg Med       Date:  1999 May-Jun       Impact factor: 1.484

2.  Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; C Wong; J Logan
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

3.  Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.

Authors:  Ikuko Miyazaki; Masato Asanuma; Francisco J Diaz-Corrales; Masaya Fukuda; Kiyoyuki Kitaichi; Ko Miyoshi; Norio Ogawa
Journal:  FASEB J       Date:  2006-01-10       Impact factor: 5.191

4.  Dopamine induces proteasome inhibition in neural PC12 cell line.

Authors:  J N Keller; F F Huang; E R Dimayuga; W F Maragos
Journal:  Free Radic Biol Med       Date:  2000-11-15       Impact factor: 7.376

5.  A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task.

Authors:  J B Richards; M J Baggott; K E Sabol; L S Seiden
Journal:  Brain Res       Date:  1993-11-12       Impact factor: 3.252

6.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

7.  Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.

Authors:  G A Ricaurte; L S Seiden; C R Schuster
Journal:  Brain Res       Date:  1984-06-15       Impact factor: 3.252

8.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

9.  The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.

Authors:  G M Farfel; G L Vosmer; L S Seiden
Journal:  Brain Res       Date:  1992-11-06       Impact factor: 3.252

10.  Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis.

Authors:  T Nakagawa; J Yuan
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

View more
  235 in total

1.  Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.

Authors:  Gabriel C Loewinger; Michael V Beckert; Hugo A Tejeda; Joseph F Cheer
Journal:  Neuropharmacology       Date:  2012-01-25       Impact factor: 5.250

2.  Correlates of substance use severity among homeless youth.

Authors:  Adeline Nyamathi; Angela Hudson; Barbara Greengold; Alexandra Slagle; Mary Marfisee; Farinaz Khalilifard; Barbara Leake
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2010-11

3.  The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.

Authors:  David M Thomas; Mariana Angoa Pérez; Dina M Francescutti-Verbeem; Mrudang M Shah; Donald M Kuhn
Journal:  J Neurochem       Date:  2010-09-06       Impact factor: 5.372

4.  Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine.

Authors:  Kimberly A Kelly; Diane B Miller; John F Bowyer; James P O'Callaghan
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

5.  Frontal white matter changes and aggression in methamphetamine dependence.

Authors:  Katharina Lederer; Jean-Paul Fouche; Don Wilson; Dan J Stein; Anne Uhlmann
Journal:  Metab Brain Dis       Date:  2015-12-15       Impact factor: 3.584

Review 6.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

7.  Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.

Authors:  Elena Martín-González; Ángeles Prados-Pardo; Santiago Mora; Pilar Flores; Margarita Moreno
Journal:  Psychopharmacology (Berl)       Date:  2018-01-08       Impact factor: 4.530

8.  Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.

Authors:  Dawn E Muskiewicz; Federico Resendiz-Gutierrez; Omar Issa; F Scott Hall
Journal:  Pharmacol Biochem Behav       Date:  2020-02-12       Impact factor: 3.533

9.  Methamphetamine-induced toxicity in indusium griseum of mice is associated with astro- and microgliosis.

Authors:  Ana Carmena; Noelia Granado; Sara Ares-Santos; Samuel Alberquilla; Yousef Tizabi; Rosario Moratalla
Journal:  Neurotox Res       Date:  2014-12-10       Impact factor: 3.911

Review 10.  Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?

Authors:  Scott Mackey; Martin Paulus
Journal:  Neurosci Biobehav Rev       Date:  2012-12-17       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.